Lindsay Tao, M.D. is Corporate Director, Global Health Policy, Johnson & Johnson, with the responsibility of regulatory policy across J&J business sectors, including pharmaceutical, medical device globally, and the focus on regulatory harmonization/convergence. Besides her role in J&J, she also represents healthcare industry in regional and global organizations, as well as takes leadership position in industry associations, includes: research -based industry coalition member, APEC (Asia Pacific Economic Cooperation) regulatory harmonization Steering Committee, Vice Chair of AHWP (Asia Harmonization Working Party， 2011 - 2014), GHTF SG1 member and UDI ad hoc working group member, and etc.
Lindsay has over 20-year experience in healthcare industry. Before Join J&J, Lindsay worked in Schering-Plough and Bristol-Mayers Squibb, held positions of increasing responsibilities in regulatory and clinical research area.